Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALEXANDRA F FITZGERALD

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Surgical

NPI
1932258993
CMS profile
10595605
Location
FAYETTEVILLE, NC

General Payments · PY2021–2024

$2,960.60

  • Reported across 173 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$693.40

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $693.40 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $180.19 10
Lilly USA, LLC $99.15 5
ABBVIE INC. $93.59 5
Acerta Pharma LLC $61.24 3
Supernus Pharmaceuticals, Inc. $41.96 2
Abbott Laboratories $39.90 2
Astellas Pharma US Inc $32.89 1
Gilead Sciences, Inc. $26.28 1
Amgen Inc. $21.29 1
GlaxoSmithKline, LLC. $17.94 1
DEXCOM, INC. $17.78 1
VIVUS LLC $16.72 1
Teva Pharmaceuticals USA, Inc. $15.96 1
PFIZER INC. $15.15 1
Tris Pharma Inc $13.36 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $810.07 48
PY2022 $716.14 46
PY2023 $740.99 43
PY2024 $693.40 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $24.53 03/14/2024 Food and Beverage Undisputed 01/23/2026 1125343737 CMS
Abbott Laboratories $15.37 12/03/2024 Food and Beverage Undisputed 01/23/2026 1125343739 CMS
ABBVIE INC. $14.94 01/22/2024 Food and Beverage Undisputed 01/23/2026 1107108217 CMS
ABBVIE INC. $15.26 02/19/2024 Food and Beverage Undisputed 01/23/2026 1107108219 CMS
ABBVIE INC. $19.04 03/18/2024 Food and Beverage Undisputed 01/23/2026 1107108221 CMS
ABBVIE INC. $22.65 04/30/2024 Food and Beverage Undisputed 01/23/2026 1107108223 CMS
ABBVIE INC. $21.70 07/24/2024 Food and Beverage Undisputed 01/23/2026 1107108225 CMS
Amgen Inc. $21.29 06/11/2024 Food and Beverage Undisputed 01/23/2026 1115625507 CMS
Astellas Pharma US Inc $32.89 10/16/2024 Food and Beverage Undisputed 01/23/2026 1139551159 CMS
AstraZeneca Pharmaceuticals LP $17.32 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105459628 CMS
AstraZeneca Pharmaceuticals LP $28.42 07/11/2024 Food and Beverage Undisputed 01/23/2026 1105765348 CMS
AstraZeneca Pharmaceuticals LP $15.50 11/04/2024 Food and Beverage Undisputed 01/23/2026 1104229671 CMS
Dexcom, Inc. $17.78 11/20/2024 Food and Beverage Undisputed 01/23/2026 1154659851 CMS
Gilead Sciences, Inc. $26.28 05/10/2024 Food and Beverage Undisputed 01/23/2026 1133732523 CMS
GlaxoSmithKline, LLC. $17.94 02/21/2024 Food and Beverage Undisputed 01/23/2026 1116584079 CMS
Lilly USA, LLC $19.56 01/30/2024 Food and Beverage Undisputed 01/23/2026 1135518894 CMS
Lilly USA, LLC $21.29 03/26/2024 Food and Beverage Undisputed 01/23/2026 1135444501 CMS
Lilly USA, LLC $21.56 05/21/2024 Food and Beverage Undisputed 01/23/2026 1135497838 CMS
Lilly USA, LLC $15.75 06/03/2024 Food and Beverage Undisputed 01/23/2026 1135512850 CMS
Lilly USA, LLC $20.99 07/09/2024 Food and Beverage Undisputed 01/23/2026 1135484201 CMS
Novo Nordisk Inc $19.67 02/12/2024 Food and Beverage Undisputed 01/23/2026 1100283712 CMS
Novo Nordisk Inc $19.82 04/15/2024 Food and Beverage Undisputed 01/23/2026 1100444995 CMS
Novo Nordisk Inc $6.58 06/27/2024 Food and Beverage Undisputed 01/23/2026 1100574152 CMS
Novo Nordisk Inc $1.03 06/27/2024 Food and Beverage Undisputed 01/23/2026 1100624844 CMS
Novo Nordisk Inc $22.17 07/22/2024 Food and Beverage Undisputed 01/23/2026 1100302131 CMS
Novo Nordisk Inc $20.12 08/12/2024 Food and Beverage Undisputed 01/23/2026 1100261195 CMS
Novo Nordisk Inc $20.92 09/16/2024 Food and Beverage Undisputed 01/23/2026 1100501959 CMS
Novo Nordisk Inc $24.36 10/07/2024 Food and Beverage Undisputed 01/23/2026 1100232326 CMS
Novo Nordisk Inc $21.05 11/25/2024 Food and Beverage Undisputed 01/23/2026 1100289126 CMS
Novo Nordisk Inc $24.47 12/09/2024 Food and Beverage Undisputed 01/23/2026 1100238268 CMS
PFIZER INC. $15.15 08/26/2024 Food and Beverage Undisputed 01/23/2026 1131892802 CMS
Supernus Pharmaceuticals, Inc. $19.94 01/02/2024 Food and Beverage Undisputed 01/23/2026 1147882920 CMS
Supernus Pharmaceuticals, Inc. $22.02 01/18/2024 Food and Beverage Undisputed 01/23/2026 1147882922 CMS
Teva Pharmaceuticals USA, Inc. $15.96 03/05/2024 Food and Beverage Undisputed 01/23/2026 1151606272 CMS
Tris Pharma Inc $13.36 05/13/2024 Food and Beverage Undisputed 01/23/2026 1147235361 CMS
VIVUS LLC $16.72 01/08/2024 Food and Beverage Undisputed 01/23/2026 1129419711 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.